CEO: Keith Gottesdiener

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.


Key numbers

Market Capitalization:753807600
Shares Outstanding: 34515000
Float: 24360721.515
Next Earning Date:2020-03-16
TTm EPS: -3.8678
TTm Dividend Rate:
200 days moving average:24.12
50 days moving average: 21.89
One day percent Change: 1.69



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,